Thank you, Madam Chair.
I have a few questions. Kirsty mentioned MS, but obviously there's a lot of interest around this table in neurological conditions. We have the subcommittee that continues to meet.
Glenda or Alain, maybe you could tell us a little bit about the current efforts in Canada with regard to neurological disorders and the investments we've seen in this fiscal year.